Non-Invasive Prenatal Testing (NIPT) Market Size to Hit USD 22.41 Bn by 2033 | 13.2% CAGR Growth | Major Companies are BGI, CENTOGENE AG, Eurofins Scientific

The global non-invasive prenatal testing (NIPT) market reached US$ 6.31 billion in 2023, with a rise of US$ 7.35 billion in 2024, and is expected to reach US$ 22.41 billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.

NIPT detects fetal genetic abnormalities using maternal blood, reducing the need for invasive procedures. Growth is driven by awareness, technological advancements, and increasing prenatal care adoption. Tests identify trisomies, sex chromosome abnormalities, and single-gene disorders. Hospitals, diagnostics labs, and obstetric clinics are key end-users. Integration with NGS and bioinformatics improves accuracy. Regulatory approvals and reimbursement policies accelerate adoption. Rising demand for safe, early-stage genetic screening supports market expansion.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Non-Invasive Prenatal Testing Market Landscape:- https://datamintelligence.com/download-sample/non-invasive-prenatal-testing-market?Ranjith

☛ Non-Invasive Prenatal Testing Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In August 2025, Illumina expanded its NIPT portfolio with a next-generation assay capable of detecting rare chromosomal abnormalities with >99% accuracy, supporting earlier and safer prenatal screening.

✅ In July 2025, Natera launched PanoramaTM NIPT enhancements integrating AI-driven risk scoring, enabling clinicians to provide more personalized genetic counseling to expectant parents.

✅ In June 2025, Quest Diagnostics rolled out expanded NIPT panels across U.S. laboratories, including microdeletion and sex chromosome analysis for comprehensive prenatal screening.

Europe: Recent Industry Developments

✅ In August 2025, Eurofins Genomics introduced enhanced NIPT solutions for European clinics, featuring non-invasive detection of trisomy 13, 18, and 21 with improved workflow efficiency.

✅ In July 2025, BGI Europe launched a next-generation NIPT assay in Germany and France, supporting high-throughput screening and early detection of fetal genetic conditions.

✅ In June 2025, Genetic Analysis AS (Norway) expanded its HarmonyTM NIPT services across the EU, integrating advanced bioinformatics for precise risk assessment and reporting.

Japan: Recent Industry Developments

✅ In August 2025, Takara Bio launched a new NIPT kit optimized for the Japanese population, enabling early detection of chromosomal abnormalities using maternal blood samples.

✅ In July 2025, Fujirebio Inc. introduced non-invasive prenatal screening services for trisomy 21, 18, and 13 with AI-assisted data interpretation for improved accuracy.

✅ In June 2025, Sysmex Corporation expanded its NIPT testing network in Japan, offering clinicians faster turnaround times and integrated genetic counseling support.

☛ Non-Invasive Prenatal Testing Market Competitive Landscape:

BGI, CENTOGENE AG, Eurofins Scientific, F. Hoffmann-La Roche Ltd (Roche Sequencing), Invitae Corporation, Illumina, Inc., Natera, Inc., Progenity, Inc., PerkinElmer Inc., Quest Diagnostics.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/non-invasive-prenatal-testing-market?Ranjith

☛ Segments Covered in the Non-Invasive Prenatal Testing Market:

By Component: Instruments & Consumables, Kits and Services

By Application: Down syndrome(trisomy 21) ,Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), Turner syndrome and Other

By End-User: Hospitals, Diagnostic Centers and Others

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Non-Invasive Prenatal Testing Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=non-invasive-prenatal-testing-market?Ranjith

☛ Regional Analysis for Non-Invasive Prenatal Testing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.